Fosamax Femur Fracture Spurred Lawsuits Across USA

Fosamax (alendronate sodium) is categorized under a class of drugs known in pharmaceutical terms as bisphosphonates. It is manufactured and under distribution by Merck & Co. The drug gained approval in 1995 for release in the market as medication against osteoporosis. The company's patent for Fosamax expired in 2008.  By then, the drug had become the third-biggest product for Merck owing to its annual sales of about $3 billion. Nonetheless, no matter how successful and effective the product as treatment for degenerative bone diseases, the drug has been associated to an atypical thighbone fracture.  Such condition has pushed some users to file a fosamax lawsuit against Merck.
What are the Side Effects of Fosamax
 There are a considerable number of adverse effects allegedly caused by the medication.  These complications range from mild to severe conditions such as nausea, abdominal cramping, flatulence, diarrhea, obstipation, and ulceration.  There are other more minor Fosamax side effects recently diagnosed by doctors.
 FDA Warning Issued in the Aftermath of Fosamax Fractures  On top of all other concerns, however, are foregoing reports that associate Fosamax to an unusual femur fractures that may occur resulting from falls even at a standing height or less. As of this writing, there are no less than three research inquiries that have been published on these incidents.  The data established the connection between Fosamax and what is known as "low energy" thighbone fractures. As a result of the review on some of this research, the Food and Drug Administration (FDA) came up with an order to manufacturers for an update on the product labeling of bisphosphonate drugs in general. The order particularly came to issue Fosamax fracture warnings.  Why Consider Filing a Femur Fracture Lawsuit Against Fosamax Manufacturer, Merck?  The burgeoning evidences that link Fosamax to low - or the lack of it - impact femur fractures has prompted at least 100 users or their loved-ones to file lawsuits against Merck involving alleged incidents of femur fracture. Anyone, in this regard, who considers joining the flurry of lawsuits must understand that, at the very least, there was a culpable evidence of suffering an abnormal thighbone fracture on the part of the user that has been diagnosed by a competent doctor. Whenever this crucial first requirement has been established, a possible plaintiff may take the next strides in filing a Fosamax lawsuit.  Estimated Compensation From a Fosamax Lawsuit  None of the Fosamax femur fracture lawsuits against Merck, so far, have yet gone to trial.  Thus, it is quite difficult to see how much could be the estimated compensation a lawsuit may yield.  There are, however, a number of lawsuits involving Fosamax jawbone injuries that have reached the trial stage.  In fact, a single plaintiff has come to recover $8 million in settlement. As one may understand how damages resulting from dangerous products are being assessed, anyone wanting to know the compensation estimate may understand the value of a probable Fosamax lawsuit settlement.  As one who is affected by injuries connected to Fosamax use, it is understandable to have many questions in mind about how to go ahead with a claim against Merck & Co., not to mention the daunting task of filing a lawsuit. Add to the situation the pains of undergoing an unnecessary injury.  It is comforting to know that there are online help in the form of legal websites that are most willing to help in cases such as this.